FDAnews
www.fdanews.com/articles/115160-sepracor-drug-lunesta-fails-in-anxiety-trial

Sepracor Drug Lunesta Fails in Anxiety Trial

March 6, 2009
Sepracor Inc. said that its insomnia drug Lunesta did not reach its main goal in a clinical trial that tested it as a treatment for generalized anxiety disorder.
BusinessWeek